Publications by authors named "Wouter van't Hof"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

7,923

Total Likes

527

Extended Reach

391,844

Social Features

126
H
Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein.
James Ropa, Scott Cooper, Maegan L Capitano, Wouter Van't Hof, Hal E Broxmeyer

Stem Cell Rev Rep· February 2021

Videos about Article: user user

2 124

View All Article and Social Media Activity
M
Mitigation of supply chain challenges in cell therapy manufacturing: perspectives from the cord blood alliance.
Patrick Killela, Kieran Herrity, Ludwig Frontier, Roger Horton, Joanne Kurtzberg, Wouter Van't Hof

Stem Cells Transl Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to' UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities' [Transplantation and Cellular Therapy 28/7 (2022) 410-410.
Maude Dumont-Lagacé, Albert Feghaly, Marie-Christine Meunier, Marcie Finney, Wouter Van't Hof

Transplant Cell Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The fulfilled promise and unmet potential of umbilical cord blood.
James Ropa, Wouter Van't Hof

Curr Opin Hematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into highly engraftable hematopoietic cells from 27-year cryopreserved umbilical cord blood.
Hal E Broxmeyer, Larry L Luchsinger, Rona Singer Weinberg, Alexandra Jimenez, Emeline Masson Frenet, Wouter Van't Hof

Cell Rep Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities.
Maude Dumont-Lagacé, Albert Feghaly, Marie-Christine Meunier, Marcie Finney, Wouter Van't Hof

Transplant Cell Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-γ and PPARδ influence the efficacy and retention of multipotent adult progenitor cells in graft vs host disease.
Fiona Carty, Hazel Dunbar, Ian J Hawthorne, Anthony E Ting, Samantha R Stubblefield, Wouter Van't Hof

Stem Cells Transl Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability.
Jeong-Su Do, Daniel Zwick, Jonathan D Kenyon, Fei Zhong, David Askew, Wouter Van't Hof

Sci Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Foxp3 expression in induced T regulatory cells derived from human umbilical cord blood vs. adult peripheral blood.
Jeong-Su Do, Fei Zhong, Alex Y Huang, Wouter J Van't Hof, Marcie Finney

Bone Marrow Transplant· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automatic Stem Cell Detection in Microscopic Whole Mouse Cryo-Imaging.
Patiwet Wuttisarnwattana, Madhusudhana Gargesha, Wouter van't Hof, Kenneth R Cooke, David L Wilson

IEEE Trans Med Imaging· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solution-Phase Crosstalk and Regulatory Interactions Between Multipotent Adult Progenitor Cells and Peripheral Blood Mononuclear Cells.
Gregory G Burrows, Wouter Van't Hof, Ashok P Reddy, Phillip A Wilmarth, Larry L David

Stem Cells Transl Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Culturing protocols for human multipotent adult stem cells.
Bart Vaes, Sara Walbers, Kristel Gijbels, David Craeye, Robert Deans, Wouter van't Hof

Methods Mol Biol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.
Richard T Maziarz, Timothy Devos, Carlos R Bachier, Steven C Goldstein, Jose F Leis, Wouter Van't Hof

Biol Blood Marrow Transplant· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human multipotent adult progenitor cells are nonimmunogenic and exert potent immunomodulatory effects on alloreactive T-cell responses.
Sandra A Jacobs, Jef Pinxteren, Valerie D Roobrouck, Ariane Luyckx, Wouter van't Hof

Cell Transplant· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human multipotent adult progenitor cells transcriptionally regulate fucosyltransferase VII.
Gregory G Burrows, Richard T Maziarz, Karen Hunady, Nicholas Lehman, Amy Raber, Wouter Van't Hof

Cytotherapy· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturing.
Shannon Eaker, Myriam Armant, Harvey Brandwein, Scott Burger, Andrew Campbell, Wouter Van't Hof

Stem Cells Transl Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis.
Gregory G Burrows, Wouter Van't Hof, Laura F Newell, Ashok Reddy, Phillip A Wilmarth

Stem Cells Transl Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart grafts tolerized through third-party multipotent adult progenitor cells can be retransplanted to secondary hosts with no immunosuppression.
Elke Eggenhofer, Felix C Popp, Michael Mendicino, Paula Silber, Wouter Van't Hof

Stem Cells Transl Med· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry.
Christopher A Bravery, Jessica Carmen, Timothy Fong, Wanda Oprea, Karin H Hoogendoorn, Wouter Van't Hof

Cytotherapy· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease.
Bart Vaes, Wouter Van't Hof, Robert Deans, Jef Pinxteren

Front Immunol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a surrogate angiogenic potency assay for clinical-grade stem cell production.
Nicholas Lehman, Rochelle Cutrone, Amy Raber, Robert Perry, Wouter Van't Hof

Cytotherapy· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.
Jeffery J Auletta, Kenneth R Cooke, Luis A Solchaga, Robert J Deans, Wouter van't Hof

Biol Blood Marrow Transplant· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease.
Magdalena Kovacsovics-Bankowski, Philip R Streeter, Kelsey A Mauch, Mark R Frey, Amy Raber, Wouter van't Hof

Cell Immunol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic pathways of adult stem cell repair.
Anthony E Ting, Robert W Mays, Mark R Frey, Wouter Van't Hof, Satish Medicetty

Crit Rev Oncol Hematol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of adult pluripotent stem cell therapies for ischemic injury and disease.
Robert W Mays, Wouter van't Hof, Anthony E Ting, Robert Perry, Robert Deans

Expert Opin Biol Ther· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis